Drazin v. Ortho Pharmaceutical Corporation

371 A.2d 827, 148 N.J. Super. 56
CourtNew Jersey Superior Court Appellate Division
DecidedJanuary 21, 1977
StatusPublished
Cited by2 cases

This text of 371 A.2d 827 (Drazin v. Ortho Pharmaceutical Corporation) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Drazin v. Ortho Pharmaceutical Corporation, 371 A.2d 827, 148 N.J. Super. 56 (N.J. Ct. App. 1977).

Opinion

148 N.J. Super. 56 (1977)
371 A.2d 827

SAUNDRA DRAZIN AND ROBERT DRAZIN, PLAINTIFFS,
v.
ORTHO PHARMACEUTICAL CORPORATION, A CORPORATION, AND WYETH LABORATORIES, A CORPORATION, DEFENDANTS.

Superior Court of New Jersey, Law Divisions.

Decided January 21, 1977.

*57 Mr. Thomas Warshaw, for plaintiffs (Messrs. Drazin and Warshaw, atorneys).

No one appearing for defendant Ortho Pharmaceutical Corp. (Messrs. Porzio, Bromberg & Newman, attorneys).

No one appearing for defendant Wyeth Laboratories (Messrs. Carton, Nary, Witt & Arvanitis, attorneys).

SELIKOFF, J.S.C.

Plaintiff Saundra Drazin for some time used "Ortho-Novum," an oral contraceptive, which she *58 alleges was prescribed for her by one Dr. William Shanik. In May or June 1973, plaintiff discontinued using Ortho-Novum and under prescription by a Dr. Sophia Preikstas, began using a contraceptive known as "Orval." Apparently both drugs were distributed by their manufacturers with warnings concerning possible harmful side effects. Plaintiff alleges that neither doctor discussed any such possibility with her.

In December, 1973, while on vacation in Florida plaintiff suffered a numbness and a burning sensation in her left hand and arm. The condition was diagnosed as a "bruit," which was corrected by two operations involving a subclavian arterial bypass.

Plaintiff remained in Florida until about April, 1974, undergoing treatment and observation, and then returned to New Jersey. Aside from this four-month period, plaintiff was not otherwise treated for the condition. Plaintiff states that the incident manifested itself in pain to her hand and arm and that the pain has since subsided.

Plaintiff brought suit on January 27, 1975 against the two present defendants who are the respective manufacturers of "Ortho-Novum" and "Orval." The suit is predicated on the theories that the drugs were negligently manufactured and that defendants breached warranties for fitness for human consumption.

On August 23, 1976 Dr. William Shanik was deposed. He testified that he was aware that the drug might have side effects. He further testified in April 1973 that he was aware of the contents of the Physician's Desk Reference as it applied to "Ortho-Novum" and of the contents of any pamphlets that were distributed with "Ortho-Novum" at that time.

Plaintiff subsequently moved to amend her complaint to name Dr. Shanik and Dr. Preikstas. She alleges that at the time oral contraceptives were prescribed the doctors knew them to be potentially unsafe but failed to inform her of the risks involved. She insists that she was unaware of any possible cause of action against the doctors until Dr. Shanik's deposition.

*59 The problem here is the statute of limitations. Plaintiff seeks to add new parties defendant more than two years after her injury. See N.J.S.A. 2A:14-2.

She cites several cases for the proposition that liberality is ordinarily exercised in granting leave to amend pleadings in order to effect a just resolution of each cause, and that in consonance with this philosophy pleadings may be amended even though an original action might be barred by the statute of limitations. Tackling v. Chrysler Corp., 77 N.J. Super. 12, 16 (Law Div. 1962); John Hancock Mut. Life Ins. Co. v. Fiorilla, 83 N.J. Super. 151, 156 (Ch. Div. 1964); De Sisto v. Linden, 80 N.J. Super. 398, 404 (Law Div. 1963); Smith v. Thermo-Fax Corp., 53 N.J. Super. 102, 105 (Law Div. 1958); Jersey City v. Hague, 18 N.J. 584, 602 (1955).

In all of these cases the amendments were permitted after the statute had run. The reasons expressed were essentially that the gist of the cause of action remained the same and no new party was sought to be added or, if a new party was sought to be added, that new party had actual notice of suit. (In both John Hancock and Smith, supra, the proposed new defendant had accepted service for the named original defendant).

Plaintiff wishes to assert an entirely new cause of action against entirely new defendants. Against the present defendants, she must establish negligent manufacture or that the drugs were unreasonably dangerous. Against the doctors she must establish the standard of care in the profession relating to the prescription of and treatment with oral contraceptives, and that the proposed defendants breached that standard. Further, there is no suggestion that either doctor had any more than casual notice of this suit before August 1976.

Plaintiff next contends that the relationship between the original parties and the physicians indicates that they are part of one cohesive unit, and suit against one tolls the statute of limitations against the other. TACA Internat'l Airlines Inc. v. Rolls-Royce Ltd., 84 N.J. Super. 140 (Law *60 Div. 1964); Dunlevy v. Martin Dennis Co., 30 N.J. Super. 446 (Law Div. 1954). In Taca, the court assessed the capital structures, personnel, operation and other attributes of Rolls-Royce, Canada, Rolls-Royce Ltd., and Rolls-Royce, Inc. It found that the three entities were so intermeshed that service upon one was notice sufficient to pass muster under due process standards as to the other two entities. Suffice it to say that plaintiff has demonstrated no such interrelationship between the present defendants and the proposed defendants.

Plaintiff contends that the proposed amendment should relate back to the time the original complaint was filed, but offers no authority for this proposition. Sinatra v. Nat'l X-Ray Products, 26 N.J. 546, 556 (1958), is cited but is factually distinguishable. In Sinatra the amendment related back, but the motion to amend was brought before the statute of limitations had run, as the statute had been tolled by N.J.S.A. 2A:14-22 (relating to nonresident defendants).

Plaintiff also contends that defendants should be estopped from pleading the statute as both had notice of the action before the statute had run. It does not appear that either defendant had any more than casual knowledge of plaintiff's suit or its underlying facts, but not such knowledge as would suggest possible involvement. (It must be remembered that neither of the proposed defendants treated the plaintiff for any condition arising out of the December 1973 incident.)

There is no merit to plaintiff's contention that a denial of this motion will preclude a consideration on the merits and deny her substantial justice. Whether the motion is granted or denied, plaintiff may still try the issues framed by her in her original complaint.

Nor is there merit to plaintiff's contention that her injury is the sort of continuous injury that will toll the statute of limitations. She is not the victim of a continuing tort: she had allegedly suffered a permanent injury.

*61 Lastly, plaintiff cites Fernandi v. Strully, 35 N.J. 434 (1961); Yerzy v. Levine, 108 N.J. Super. 222 (App. Div. 1970), and Lopez v. Swyer, 115 N.J. Super. 237 (App. Div. 1971), contending that the statute of limitations was tolled by virtue of New Jersey's discovery rule. In Fernandi the Supreme Court said (35 N.J.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Allen v. Commonwealth, Department of Corrections
103 A.3d 365 (Commonwealth Court of Pennsylvania, 2014)
Drazin v. Shanik
407 A.2d 1274 (New Jersey Superior Court App Division, 1979)

Cite This Page — Counsel Stack

Bluebook (online)
371 A.2d 827, 148 N.J. Super. 56, Counsel Stack Legal Research, https://law.counselstack.com/opinion/drazin-v-ortho-pharmaceutical-corporation-njsuperctappdiv-1977.